Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 37 Records) |
Query Trace: Small Cell Lung Carcinoma and KRAS[original query] |
---|
Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. International journal of clinical and experimental pathology 2013 6 (9): 1880-9. Liu Yan, Wu Bing-Quan, Zhong Hao-Hao, Hui Pei, Fang Wei-Ga |
Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients. Genes, chromosomes & cancer 2013 Dec 52 (12): 1141-9. Mäki-Nevala Satu, Kaur Sarhadi Virinder, Tuononen Katja, Lagström Sonja, Ellonen Pekka, Rönty Mikko, Wirtanen Aino, Knuuttila Aija, Knuutila Saka |
Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma. Lung cancer (Amsterdam, Netherlands) 2014 Nov 86 (2): 255-61. Zhao Ni, Wilkerson Matthew D, Shah Usman, Yin Xiaoying, Wang Anyou, Hayward Michele C, Roberts Patrick, Lee Carrie B, Parsons Alden M, Thorne Leigh B, Haithcock Benjamin E, Grilley-Olson Juneko E, Stinchcombe Thomas E, Funkhouser William K, Wong Kwok-Kin, Sharpless Norman E, Hayes D Ne |
Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International journal of environmental research and public health 2014 Sep 11 (9): 9491-502. Yilmaz Ahmet, Mohamed Nehad, Patterson Kara A, Tang Yan, Shilo Konstantin, Villalona-Calero Miguel A, Davis Michael E, Zhou Xiaoping, Frankel Wendy, Otterson Gregory A, Beall Howard D, Zhao Weiqia |
Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2014 Mar 22 (3): 231-5. Adams Julia A, Post Kristin M, Bilbo Sarah A, Wang Xiaoyan, Sen Joyashree D, Cornwell Anita J, Malek Amanda J, Cheng Lia |
Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clinical lung cancer 2015 Jan 16 (1): 24-32. Mak Raymond H, Hermann Gretchen, Lewis John H, Aerts Hugo J W L, Baldini Elizabeth H, Chen Aileen B, Colson Yolonda L, Hacker Fred H, Kozono David, Wee Jon O, Chen Yu-Hui, Catalano Paul J, Wong Kwok-Kin, Sher David |
Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun . Dragoj Miodrag, Milosevic Zorica, Bankovic Jasna, Dinic Jelena, Pesic Milica, Tanic Nikola, Stankovic Tija |
[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015 Apr 18 (4): 199-205. Zhang Zhihui, Wu Xilan, Ying Jianming, Li Junling, Qiu Tian, Guo Huiqin, Zhao Huan, Shan Ling, Ling Y |
Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients. Pathology oncology research : POR 2015 Jul 21 (3): 675-87. Das Bibhu Ranjan, Bhaumik Sangeet, Ahmad Firoz, Mandsaurwala Aziz, Satam Hee |
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma. Oncotarget 2016 Jul . Rachiglio Anna Maria, Abate Riziero Esposito, Sacco Alessandra, Pasquale Raffaella, Fenizia Francesca, Lambiase Matilde, Morabito Alessandro, Montanino Agnese, Rocco Gaetano, Romano Carmen, Nappi Anna, Iaffaioli R Vincenzo, Tatangelo Fabiana, Botti Gerardo, Ciardiello Fortunato, Maiello Monica R, De Luca Antonella, Normanno Nico |
Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Oncotarget 2016 Jul . Zhang Shirong, Xia Bing, Jiang Hong, Wang Limin, Xu Rujun, Shi Yanbin, Zhang Jianguang, Xu Mengnan, Cram David S, Ma Shengl |
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr . Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San |
Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Cancer cytopathology 2016 Mar . Allison Derek B, Lilo Mohammed T, Geddes Susan, Pallavajjalla Aparna, Askin Frederic, Gabrielson Edward, Zheng Gang, Li Qing K |
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Tong Joanna H, Yeung Sai F, Chan Anthony Wh, Chung Lau Y, Chau Shuk L, Lung Raymond Wai Ming, Tong Carol Y, Chow Chit, Tin Edith Ky, Yu Yau H, Li Hui, Pan Yi, Chak Wing P, Ng Calvin Sh, Mok Tony S K, To Ka |
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients. Pathology 2017 Aug . Russell Prudence A, Rogers Toni-Maree, Solomon Benjamin, Alam Naveed, Barnett Stephen A, Rathi Vivek, Williams Richard A, Wright Gavin M, Conron Matth |
Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao. The clinical respiratory journal 2017 Jul . Chan Kin Iong, Vong Hong Ting, Sin Lai Fong, Yip Yuk Ching, Zhong Xue Yun, Wen Jian Mi |
Comprehensive profiling and quantitation of oncogenic mutations in non-small cell lung carcinoma using single-molecule amplification and re-sequencing technology. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Feb 39 (2): 1010428317691413. Shi Jian, Yuan Meng, Wang Zhan-Dong, Xu Xiao-Li, Hong Lei, Sun Shengl |
RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov . Hayashi Takuo, Desmeules Patrice, Smith Roger S, Drilon Alexander, Somwar Romel, Ladanyi Ma |
KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology 2018 Feb . Mehrad Mitra, Roy Somak, LaFramboise William A, Petrosko Patti, Miller Caitlyn, Incharoen Pimpin, Dacic San |
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations. Cancer cytopathology 2019 Apr . Mei Ping, Shilo Konstantin, Wei Lai, Shen Rulong, Tonkovich Dena, Li Zai |
Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2). Clinical lung cancer 2019 1 20 (3): 222-230. Beau-Faller Michèle, Texier Matthieu, Blons Hélène, Richard Nicolas, Escande Fabienne, Melaabi Samia, Lizard Sarab, De Fraipont Florence, Longchampt Elisabeth, Morin Franck, Zalcman Gérard, Pignon Jean-Pierre, Cadranel Jacqu |
Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India). Heliyon 2020 3 6 (2): e03488. Din Shah Naseer Ue, Ali Md Niamat, Ganai Bashir A, Mudassar Syed, Khan Mosin Saleem, Kour Jasbir, Waza Ajaz Ahmad, Rasool Malik Tariq, Lone Aabid Maqbo |
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells. American journal of translational research 2020 3 12 (2): 409-427. Lee Mi-Heon, Yanagawa Jane, Tran Linh, Walser Tonya C, Bisht Bharti, Fung Eileen, Park Stacy J, Zeng Gang, Krysan Kostyantyn, Wallace William D, Paul Manash K, Girard Luc, Gao Boning, Minna John D, Dubinett Steven M, Lee Jay |
Kirsten rat sarcoma virus protein overexpression in adenocarcinoma lung: Association with clinicopathological and histomorphological features. Journal of carcinogenesis 2020 19 9. Pandey Rahul Kumar, Shukla Saumya, Hadi Rahat, Husain Nuzhat, Islam Mohammad Hayatul, Singhal Ashish, Tripathi Surya Kant, Garg Raj |
Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer. Journal of thoracic disease 2023 3 15 (2): 365-375. Ou Limin, Cai Xiuyu, Zeng Wenchuang, Huang Liyan, Deng Qiuhua, Tang Hailing, Chen Zhuxing, Zhou Huan, Lin Yongping, Liu Liping, Liang Wenh |
Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: